Business and Finance

Industrialized collaboration is critical to taking next-generation cell and gene therapies to the next level—if companies can build on pandemic-partnering momentum

Separation process expected to be completed in 18-24 months

Expansion expected to more than double the plant’s footprint

CDMO’s expansion of Hopkinton, MA facility will include seven new ISO 7 cGMP suites

Deal expected to boost firm’s offerings via FDS's delivery system services

Partnership further increases investment firm’s repertoire in healthcare space

Boston area facility will focus heavily on cold chain services

Parties expect improved design and selection of eCOAs in decentralized clinical trials

ScriptDrop, Adheris Health collaborate to assist patients with their medication regimens

Award will support research based on use of real-world evidence in clinical oncology setting

Acquisition reportedly increases AI accessibility across life sciences organizations

Development project features additional manufacturing suites, expansion of storage capabilities

Facility features cell storage for CAR-T cell treatments

mRNA jab maker plans to initially produce 50 million Covid vaccine doses per year

Deal provides ten23 with drug product development, biologic manufacturing experience

Biologics manufacturer to construct new C&GT facility to support expansion

Facility meets cGMP standards for radiopharmaceutical production

CDTMO’s fourth site further expands its support of cell therapy delivery and access

Transaction enhances CDMO’s services when it comes to drug product offerings

Research collaboration centered around AAV capsids

Deal is expected to boost manufacturer’s European presence, Aceto executives say

Among areas, financial commitment will power clinical and commercial manufacturing suites

Company officials predict 500 million vaccine doses per year to be produced via the center, which will offer fill-finish, packaging services

Previous merger earns clinical research company $235 million as it looks to advance patient enrollment

Company officials believe new facility will help meet ongoing demand for temperature-controlled packaging

Using AI and data engineering insight, purchase offers customers potential to shorten clinical trials and accelerate time to commercialization

Manufacturing facility to provide 1.5 million square feet of bioproduction technologies

Will feature laboratories intended for R&D

Collaboration centers around providing assistance to multiple links in the clinical trial chain, from participants to providers

Development of additional 29,000 square feet addresses med tech company’s internal production capabilities